Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rankning i aktier #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aktiekurs
$0.00023723
Senast synkroniserad: 2024-08-26
Marknadsvärde
$1.41K
Förändring (1 dag)
111.67%
Förändring (1 år)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Kategori

Historik för aktiesplit för Pharnext S.A. (ALPHA)
Aktien Pharnext S.A. (symbol: ALPHA) har genomgått totalt 4 aktiesplitar.
Den senaste spliten skedde den Feb 15, 2024.
En ALPHA-aktie köpt före Nov 23, 2022 motsvarar nu 4.0E-16 ALPHA-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2024-02-15 1:10000 x0.0001 x4.0E-16
2023-09-18 1:5000 x0.0002 x4.0E-12
2023-05-10 1:10000 x0.0001 x2.0E-8
2022-11-23 1:5000 x0.0002 x0.0002
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR